4.7 Review

The history of neuromyelitis optica

Journal

JOURNAL OF NEUROINFLAMMATION
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1742-2094-10-8

Keywords

Neuromyelitis optica; Devic's syndrome; Devic's disease; Myelitis; Optic neuritis; Multiple sclerosis; Nomenclature; Diagnostic criteria; History of neurology

Funding

  1. European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS)
  2. Merck Serono
  3. Bayer HealthCare

Ask authors/readers for more resources

The discovery of a novel serum autoantibody (termed NMO-IgG or AQP4-Ab) in a subset of patients in 2004 has revived interest in neuromyelitis optica (NMO). While the history of classical multiple sclerosis has been extensively studied, only little is known about the history of NMO. In the present article, we provide a comprehensive review of the early history of this rare but intriguing syndrome. We trace the origins of the concept of NMO in the 19th century medical literature and follow its evolution throughout the 20th and into the 21st century. Finally, we discuss recent proposals to revise the concept of NMO and explain why there is indeed a need for a more systematic and descriptive nomenclature.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available